{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T17:09:28Z","timestamp":1788887368456,"version":"build-2803163510"},"reference-count":29,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:00:00Z","timestamp":1788825600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and Objectives: Acute chest syndrome (ACS) is the leading cause of sickle cell disease (SCD)-related mortality (~25% of deaths). A subset of patients develops severe respiratory compromise requiring intensive care unit (ICU) admission or mechanical ventilation (MV), a high-risk group with widely variable reported mortality. This review aimed to determine the mortality rates, ICU\/hospital length of stay, and reported complications among adult SCD patients with ACS admitted to the ICU or placed on MV. Materials and Methods: This PRISMA 2020-compliant systematic review was prospectively registered on PROSPERO (CRD420261295111). Cochrane Library, PubMed, Web of Science, ScienceDirect, EBSCOhost, and Scopus were searched without date restriction. Due to substantial clinical and methodological heterogeneity, the pre-specified meta-analysis was replaced by a narrative synthesis. Methodological quality was assessed using the Newcastle\u2013Ottawa Scale. Results: Eight studies were included (one multicenter prospective cohort, two national database studies, three single-center cohorts, and one before\u2013after antimicrobial stewardship study). In-hospital mortality ranged from 0.95% to 3.8%; overall mortality including follow-up reached 12.9% in a dedicated ICU cohort, a distinct endpoint from in-hospital death. Mechanical ventilation was the strongest indicator of mortality, with odds ratios of 67.53 (MV &lt; 96 h) and 8.73 (MV \u2265 96 h) in the largest national cohort. Tricuspid regurgitant jet velocity \u22653 m\/second was associated with cor pulmonale, invasive ventilation, and all immediate hospital deaths in one severe cohort. Documented bacterial infection was uncommon (10\u201320% of episodes), despite frequent antibiotic use, and procalcitonin-guided discontinuation safely reduced antibiotic exposure. All eight included studies were rated high quality on the Newcastle\u2013Ottawa Scale (score \u2265 7\/9). Conclusions: Mechanical ventilation, pulmonary hypertension\/cor pulmonale, and comorbidity burden are the most consistent markers of poor outcome in ACS. The findings support early recognition, severity-based respiratory support, and antimicrobial stewardship, but should be interpreted cautiously given the substitution of narrative synthesis for meta-analysis, heterogeneous populations, and the geographic concentration of the included studies.<\/jats:p>","DOI":"10.3390\/medicina62091731","type":"journal-article","created":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T16:46:04Z","timestamp":1788885964000},"page":"1731","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Mortality Associated with Intensive Care Unit Admission and Mechanical Ventilation in Adults with Acute Chest Syndrome: A Systematic Review"],"prefix":"10.3390","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-8109-5376","authenticated-orcid":false,"given":"Mohammed Essam","family":"Shaybah","sequence":"first","affiliation":[{"name":"College of Medicine, Umm Al-Qura University, Makkah 24382, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-7611-3815","authenticated-orcid":false,"given":"Osama","family":"Alsehli","sequence":"additional","affiliation":[{"name":"College of Medicine, Umm Al-Qura University, Makkah 24382, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-2920-8416","authenticated-orcid":false,"given":"Ali","family":"Al-Harthi","sequence":"additional","affiliation":[{"name":"College of Medicine, Umm Al-Qura University, Makkah 24382, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-1136-5383","authenticated-orcid":false,"given":"Nada","family":"Bajuaifer","sequence":"additional","affiliation":[{"name":"Department of Hematology & Immunology, College of Medicine, Umm Al-Qura University, Makkah 24382, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-8476-1214","authenticated-orcid":false,"given":"Mohammed","family":"Bafaqih","sequence":"additional","affiliation":[{"name":"College of Medicine, Umm Al-Qura University, Makkah 24382, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-0115-4687","authenticated-orcid":false,"given":"Mohammed","family":"Alzhrani","sequence":"additional","affiliation":[{"name":"College of Medicine, Umm Al-Qura University, Makkah 24382, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-0874-4189","authenticated-orcid":false,"given":"Abdulrhman","family":"Alasmari","sequence":"additional","affiliation":[{"name":"College of Medicine, Umm Al-Qura University, Makkah 24382, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-7154-4526","authenticated-orcid":false,"given":"Abdulghafur","family":"Kashgari","sequence":"additional","affiliation":[{"name":"College of Medicine, Umm Al-Qura University, Makkah 24382, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-6060-4620","authenticated-orcid":false,"given":"Omar M.","family":"Alhazmi","sequence":"additional","affiliation":[{"name":"College of Medicine, Umm Al-Qura University, Makkah 24382, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-9143-6074","authenticated-orcid":false,"given":"Anas Sameer","family":"Munshi","sequence":"additional","affiliation":[{"name":"College of Medicine, Umm Al-Qura University, Makkah 24382, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,9,8]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1056\/NEJMra1510865","article-title":"Sickle Cell Disease","volume":"376","author":"Piel","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_2","first-page":"e95112","article-title":"Emerging Therapies for Sickle Cell Disease: From Symptom Management to Curative Gene Therapy","volume":"17","author":"Duesberg","year":"2025","journal-title":"Cureus"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1001\/archinte.1979.03630380047016","article-title":"\u201cAcute Chest Syndrome\u201d in Adults With Sickle Cell Anemia: Microbiology, Treatment, and Prevention","volume":"139","author":"Charache","year":"1979","journal-title":"Arch. Intern. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"150755","DOI":"10.1016\/j.tmrv.2023.150755","article-title":"Acute Chest Syndrome in Sickle Cell Disease","volume":"37","author":"Bhasin","year":"2023","journal-title":"Transfus. Med. Rev."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2970","DOI":"10.1182\/bloodadvances.2024015139","article-title":"Triaging acute chest syndrome clinical decision-making using bedside SaO2\/FiO2 ratio","volume":"9","author":"Wesevich","year":"2025","journal-title":"Blood Adv."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1111\/bjh.18777","article-title":"Acute chest syndrome in adult patients with sickle cell disease: The relationship with the time to onset after hospital admission","volume":"201","author":"Cheminet","year":"2023","journal-title":"Br. J. Haematol."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Allareddy, V., Roy, A., Lee, M.K., Nalliah, R.P., Rampa, S., Allareddy, V., and Rotta, A.T. (2014). Outcomes of Acute Chest Syndrome in Adult Patients with Sickle Cell Disease: Predictors of Mortality. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0094387"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1007\/s00277-025-06233-0","article-title":"Understanding the role of asthma in acute chest syndrome: A comparative analysis of patients with and without asthma","volume":"104","author":"Rodriguez","year":"2025","journal-title":"Ann. Hematol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1164\/rccm.200710-1606OC","article-title":"Pulmonary hypertension and cor pulmonale during severe acute chest syndrome in sickle cell disease","volume":"177","author":"Leon","year":"2008","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1056\/NEJM200006223422502","article-title":"Causes and Outcomes of the Acute Chest Syndrome in Sickle Cell Disease","volume":"342","author":"Vichinsky","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Alsaeed, A., Aleid, R., Amin, O., Alansari, A., Aleid, H., and Aleid, M. (2025). Infectious Etiologies and Antimicrobial Management of Acute Chest Syndrome in Adult Sickle Cell Disease Patients: Pathogen Identification Patterns and Clinical Outcomes from a Five-Year Retrospective Study in Eastern Saudi Arabia. Pathogens, 14.","DOI":"10.20944\/preprints202511.0320.v1"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Razazi, K., Gendreau, S., Cuquemelle, E., Khellaf, M., Guillaud, C., Godeau, B., Melica, G., Moutereau, S., Gomart, C., and Fourati, S. (2020). Procalcitonin to Reduce Antibiotic Exposure during Acute Chest Syndrome in Adult Patients with Sickle-Cell Disease. J. Clin. Med., 9.","DOI":"10.3390\/jcm9113718"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1002\/ajh.24539","article-title":"Rapidly progressive acute chest syndrome in individuals with sickle cell anemia: A distinct acute chest syndrome phenotype","volume":"91","author":"Chaturvedi","year":"2016","journal-title":"Am. J. Hematol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1182\/blood.V89.5.1787","article-title":"Acute Chest Syndrome in Sickle Cell Disease: Clinical Presentation and Course","volume":"89","author":"Vichinsky","year":"1997","journal-title":"Blood"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Chang, R., Elhusseiny, K.M., Yeh, Y.C., and Sun, W.Z. (2021). COVID-19 ICU and mechanical ventilation patient characteristics and outcomes\u2014A systematic review and meta-analysis. PLoS ONE, 16.","DOI":"10.1371\/journal.pone.0246318"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1097\/CCM.0000000000000316","article-title":"Outcomes of adult patients with sickle cell disease admitted to the ICU: A case series","volume":"42","author":"Cecchini","year":"2014","journal-title":"Crit. Care Med."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Fukuda, Y., Tanaka, A., Homma, T., Kaneko, K., Uno, T., Fujiwara, A., Uchida, Y., Suzuki, S., Kotani, T., and Sagara, H. (2021). Utility of SpO2\/FiO2 ratio for acute hypoxemic respiratory failure with bilateral opacities in the ICU. PLoS ONE, 16.","DOI":"10.1371\/journal.pone.0245927"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ajem.2021.01.092","article-title":"Assessment of the SpO2\/FiO2 ratio as a tool for hypoxemia screening in the emergency department","volume":"44","author":"Catoire","year":"2021","journal-title":"Am. J. Emerg. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s13054-025-05317-7","article-title":"Limitations of SpO2\/FiO2-ratio for classification and monitoring of acute respiratory distress syndrome\u2014An observational cohort study","volume":"29","author":"Erlebach","year":"2025","journal-title":"Crit. Care"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1056\/NEJMoa035477","article-title":"Pulmonary Hypertension as a Risk Factor for Death in Patients with Sickle Cell Disease","volume":"350","author":"Gladwin","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Gladwin, M.T., Barst, R.J., Gibbs, J.S.R., Hildesheim, M., Sachdev, V., Nouraie, M., Hassell, K.L., Little, J.A., Schraufnagel, D.E., and Krishnamurti, L. (2014). Risk Factors for Death in 632 Patients with Sickle Cell Disease in the United States and United Kingdom. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0099489"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"E75","DOI":"10.1002\/ajh.23944","article-title":"N-terminal pro-B-type natriuretic peptide, tricuspid jet flow velocity, and death in adults with sickle cell disease","volume":"90","author":"Schimmel","year":"2015","journal-title":"Am. J. Hematol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1182\/blood-2025-2596","article-title":"Addressing functional asplenia in sickle cell disease: A quality improvement approach to improve vaccination rates","volume":"146","author":"Keiser","year":"2025","journal-title":"Blood"},{"key":"ref_25","first-page":"546","article-title":"Infections in sickle cell disease","volume":"110","author":"Scourfield","year":"2025","journal-title":"Haematologica"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S1473-3099(17)30592-3","article-title":"Effect of procalcitonin-guided antibiotic treatment on mortality in acute respiratory infections: A patient level meta-analysis","volume":"18","author":"Schuetz","year":"2018","journal-title":"Lancet Infect. Dis."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1186\/s13054-018-2125-7","article-title":"Effect of procalcitonin-guided antibiotic treatment on clinical outcomes in intensive care unit patients with infection and sepsis patients: A patient-level meta-analysis of randomized trials","volume":"22","author":"Wirz","year":"2018","journal-title":"Crit Care"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1056\/NEJMoa1802670","article-title":"Procalcitonin-Guided Use of Antibiotics for Lower Respiratory Tract Infection","volume":"379","author":"Huang","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.3324\/haematol.11213","article-title":"Asthma is associated with Increased mortality in individuals with sickle cell anemia","volume":"92","author":"Boyd","year":"2007","journal-title":"Haematologica"}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/62\/9\/1731\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T16:51:16Z","timestamp":1788886276000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/62\/9\/1731"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,8]]},"references-count":29,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["medicina62091731"],"URL":"https:\/\/doi.org\/10.3390\/medicina62091731","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,8]]}}}